ARGOS THERAPEUTICS INC — Form D

ARGOS THERAPEUTICS INC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-27. The offering totals $60.0M, of which $22.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Jeffrey D AbbeyDirectorDurham, NC
Hubert D BirnerDirectorWaltham, MA
David A GryskaDirectorNew York, NY
Jean A LamarreDirectorMontreal, A8
Andrei A PetrovDirectorMoscow, 1Z
Philip R TracyDirectorDurham, NC
Brian R UnderdownDirectorToronto, A6
Sander D van DeventerDirectorNaarden, P7
Jeffrey D AbbeyExecutive OfficerDurham, NC
Lori A HarrelsonExecutive OfficerDurham, NC
Frederick M MiesowiczExecutive OfficerDurham, NC
Charles A NicoletteExecutive OfficerDurham, NC
Douglas A PlessingerExecutive OfficerDurham, NC
B. Jefferson ClarkDirectorDurham, NC
Monique A LaliberteDirectorMontreal, A8
Sander Jefferson van DeventerDirectorNaarden, P7
Michel Jefferson GrecoDirectorSte Foy Les Lyon, I0
Ines Jefferson HolzbaurDirectorMontreal, A8
Charles A. NicoletteExecutive OfficerDurham, NC
Hubert D. BirnerDirectorBoston, MA
Philip R. TracyDirectorDurham, NC
Douglas A. PlessingerExecutive OfficerDurham, NC
Brian R. UnderdownDirectorToronto, A6
Lori A. HarrelsonExecutive OfficerDurham, NC
Frederick M. MiesowiczExecutive OfficerDurham, NC

Other filings by this issuer (4)

FiledFormOfferingSold
2012-09-11D$16.0M$16.0M
2012-04-24D$50.0M$9.0M
2011-07-29D$3.5M$3.5M
2010-09-20D$6.0M$4.9M

More